Pharmaceuticals - Babraham, England, United Kingdom
Senexis is a growing, small-molecule drug development company that is committed to revolutionising the treatment of diseases resulting from the inevitable process of ageing. Senexis is advancing a pipeline of novel treatments for diseases resulting from the toxicity of amyloid-like proteins. Our pipeline is currently focused on discovering therapies for the treatment of Alzheimer's disease.